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INTRODUCTION
Ewing's sarcoma/primitive neuroectodermal tumors (EWS/PNET) are malignant soft-tissue tumors occurring most commonly in the bones in children but increasingly common in the soft-tissues in young adult. Nearly 90% of ES/PNET have a genetic EWS-friend leukemia virus integration-1 (FLI1) fusion protein which results from a specific t (11;22). The carboxy-terminus of FLI1 in immunochemical stain is sensitive and extremely specific for the diagnosis of ES/PNET. [1] ES/PNET is uncommon in the mesenteric area. It is objectively confirmed by the immunohistochemical stains and molecular analysis. There are only 36 cases of intestinal EWS/PNET have been previously documented and the author has collected all previous cases of a published report of intestinal ES/PNET in Table 1 . Therapeutically, the earlier published cases were almost treated with operation and adjuvant computed tomography (CT), and with elective radiotherapy in some cases.
CASE REPORT
Ms. B is a 25-year-old woman presented to the author's department reporting abdominal tenderness and poor appetite for the past 3 days. She was afebrile and denied any history of the systemic disease or traumatic surgery, and she had well oriented and conscious on general physical examination. Her laboratory tests were all within normal limits, and tumor markers including carcinoembryonic antigen and cancer antigen 19-9 were standard. Abdominal CT showed a homogenous 9 cm × 6 cm mass in the lower abdomen with the invasion of the ileum [ Figure 1a ]. The clinically and radiologically differential diagnoses included gastrointestinal stromal tumor, lymphoma, and leiomyosarcoma. Given that malignancy was suspected, she underwent exploratory laparotomy.
Access this article online
Website: www.ijpmonline.org This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
Exploratory laparotomy identified the tumor about 40 cm from the lower region of the ligament of Treitz. The specimen revealed a solid homogenous tumor mass measured 9.2 cm × 5.9 cm × 4 cm in the lower abdomen with an invasion of the ileum [ Figure 1b ].
Under the histological examination of the tumor, hypercellular monomorphic small blue round cells with scant cytoplasm and focal clearing of the cytoplasm were arranged in sheets and compact nest patterns microscopically [ Figure 2a ]. The tumor cells lacked well-formed rosettes. The round-to-oval nuclei had finely distributed chromatin and a small nucleolus [ Figure 2b ]. Mitotic figures were infrequent. Besides, foci of necrosis, hemorrhage, and edema within the tumor were noted. The initial differential diagnoses included small cell carcinoma, lymphoma/leukemia, synovial sarcoma, EWS/PNET, neuroblastoma, alveolar rhabdomyosarcoma, and desmoplastic small round cell tumor.
A panel of immunochemical markers revealed that the tumor cells were positive for vimentin, CD99, FLI1, and NKX2.2 expressed in a membranous fashion for CD99 and showing nuclear reactivity for NKX2.2 [ Figure 3a and b] as well as nuclear reactivity for FLI1 [ Figure 3c ]. Staining for the other markers, including leukocyte common antigen markers and neuroendocrine markers, were all negative. [2, 3] A genetic fluorescence in situ hybridization (FISH) analysis for the EWSR1 gene showed a break-apart signal pattern and revealed a t (11-22) translocation of the tumor cells, indicating a translocation involving the EWS gene [ Figure 4 ]. [4] Adjuvant chemotherapy was suggested; however, Ms. B defaulted for any further treatment, and she was lost to follow-up.
DISCUSSION
EWS/PNET usually occurs in the soft tissues, bones, or central nervous system as a sporadic aggressive malignant small round cell tumor. EWS/PNET were first documented by Stout in 1918. [5] EWS/PNETs can be classified into two main groups: central EWS/PNET that grow from the central nervous system and peripheral pEWS/PNET that grow somewhere outside the central nervous system. [6] EWS/PNETs are generally identified in children and young adults along the central axis, mostly in the soft tissue or bone. This aggressive and unusual tumor has been seen in the esophagus, liver, pancreas, adrenal gland, kidneys, prostate, urinary bladder, and gynecological organs. [7] To the best of our knowledge, only 36 cases of intestinal EWS/PNET have been previously documented. In summary, the author has collected all previous cases of a published report of intestinal ES/PNET in Table 1 . The small intestine besides the mesentery is the most common location, followed by the mesocolon and duodenum. The current study reveals another rare area, i.e., the ileocecum. [8] Currently, there are no blood markers reported to be helpful for diagnosing EWS/PNET. The histologic manifestation of the tumor typically consists of round-to-ovoid hyperchromatic cells with little cytoplasm, arranged in a solid nest growth pattern with varying rosette-like formations. It is possible to distinguish EWS/PNETs from other small round-cell tumors by immunohistochemical stains and molecular analysis; however, it is hard to differentiate EWS/PNET from other small blue round blue cell tumors. [9] The FISH analysis of EWS/PNET in our case revealed the rearrangement of the EWSR1 gene. Mhawech-Fauceglia et al.
proved that a combination of CD99 and FLI1 is the most sensitive and specific test panel for the diagnosis of EWS/PNET. [6] Recently, Yoshida et al. reported that a significant target of EWS-FLI1, the NKX2.2 gene, is a useful marker for EWS/PNET, with a sensitivity of 93% and a specificity of 89%. [3] The genetic feature is the occurrence of a specific translocation, t (11; 22) (q24; q12), revealed in 90%-95% of patients, which is critical for an accurate diagnosis, selection of the most favorable treatment, and prognosis. [2, 4, 10] Currently, there is no preferred conventional treatment modality for intestinal EWS/PNET. Complete surgical excision provides the greatest chance of survival, and adjuvant radiotherapy may decrease local recurrence. Li et al.'s demographic research has indicated that EWS is far less frequent in Asian than in the United States Caucasian population. Nevertheless, whether the result is associated with genetic background differences still needed to be studied. [7] In conclusion, we have reported for the first time an unusual case of mesenteric localized ES/PNET in the Asian population, as confirmed by histopathologic examination and genetic analyses. The present case, together with previous studies, has expanded the spectrum of the tumor in the small intestine and the absence of metastasis of this patient is the critical fact in the Ms. B's prognosis. 
